Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 46, 2014 - Issue 5
Submit an article Journal homepage
271
Views
32
CrossRef citations to date
0
Altmetric
Review Article

Levamisole-Adulterated Cocaine: What about in European Countries?

Céline EidenPharmacist, Centre for Evaluation and Information on Pharmacodependance-Addictovigilance, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, FranceCorrespondence[email protected]
, Pharm.D., Ph.D.,
Caroline DiotPharmacist, Centre for Evaluation and Information on Pharmacodependance-Addictovigilance, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, France
, Pharm.D.,
Olivier MathieuAssistant Professor in Medical Pharmacology, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, UM1, Montpellier, France
, Pharm.D., Ph.D.,
Michel MallaretHead of Pharmacology Department, Centre for Evaluation and Information on Pharmacodependance-Addictovigilance, Medical Pharmacology and Toxicology Department, University Hospital of Grenoble, Grenoble, France
, M.D. &
Hélène PeyrièreAssistant Professor in Clinical Pharmacy, Centre for Evaluation and Information on Pharmacodependance-Addictovigilance, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, UM1, Montpellier, France
, Pharm.D., Ph.D.
Pages 389-392 | Published online: 03 Nov 2014

REFERENCES

  • Álvarez Díaz, H.; Marińo Callejo, A.I.; García Rodríguez, J.F.; Rodríguez Pazos, L.; Gómez Buela, I. & Bermejo Barrera, A.M. 2013. ANCA-positive vasculitis induced by levamisole-adulterated cocaine and nephrotic syndrome: The kidney as an unusual target. Am J Case Rep. 30 (14 ): 557 –61.
  • Bertol, E.; Mari, F.; Di Milia, M.G.; Politi, L.; Furlanetto, S. & Karch, S.B. 2011. Determination of aminorex in human urine samples by GC-MS after use of levamisole. J Pharm Biomed Anal. 55 (5 ): 1186 –9.
  • Brabant, W.; Mazure, D.; Vantilborgh, A.; Van Heeringen, C. & Lemmens, G. 2012. Agranulocytosis after cocaine use: A case of suspected levamisole contamination in Belgium. Clin Neurol Neurosurg. 114 (8 ): 1159 –60.
  • Brunt, T.M.; Rigter, S.; Hoek, J.; Vogels, N.; Van Dijk, P. & Niesink, R.J.M. 2009. An analysis of cocaine powder in the Netherlands: Content and health hazards due to adulterants. Addiction. 104 (5 ): 798 –805.
  • Evrard, I.; Legleye, S. & Cadet-Tairou, A. 2010. Composition, purity and perceived quality of street cocaine in France. Int J Drug Policy. 21 (5 ): 399 –406.
  • Fucci, N. & Agius, R. 2013 Levamisole in gastric content after unusual intake of heroin and cocaine. J Forensic Toxicol Pharmacol. 2: 1.
  • Hofmaier, T.; Luf, A.; Seddik, A.; Stockner, T.; Holy, M.; Freissmuth, M.; Ecker, G.F.; Schmid Sitte, H.H. & Kudlacek, O. 2013. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochem Int. 73: 32–41. doi:10.1016/j.neuint.2013.11.010.
  • Karch, S.B.; Mari, F.; Bartolini, V. & Bertol, E. 2012. Aminorex poisoning in cocaine abusers. Int J Cardiol. 158 (3 ): 344 –346.
  • Karch, S.B.; Defraia, B.; Messerini, L.; Mari, F.; Vaiano, F. & Bertol, E. 2014. Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user. Forensic Sci Int. 240: e7–10. doi:10.1016/j.forsciint.2014.03.028.
  • Lador, F.; Beghetti, M. & Rochat, T. 2009. Early detection and treatment of pulmonary arterial hypertension. Rev Med Suisse. 18 (226 ): 2317 –21.
  • Larocque, A. & Hoffman, R.S. 2012. Levamisole in cocaine: Unexpected news from an old acquaintance. Clin Toxicol (Phila) 50 (4 ): 231 –241.
  • Lazareth, H.; Peytavin, G.; Polivka, L. & Dupin, N. 2012. The hairy-print for levamisole-induced vasculitis. BMJ Case Rep. 10: 1 –3.
  • Lemaignen, A.; Goulenok, T.; Kalamarides, S.; Plat, A.; Pfau, G. & Fantin, B. 2013. Agranulocytosis and vasculitis in a cocaine addict: Levamisole, the hidden culprit. Rev Med Interne. 35: 676–679. doi:10.1016/j.revmed.2013.10.337.
  • Lera, J.M.; Gimenez, A.; Jimenez, D.; Irarrazaval, I. & Linares, M. 2013. Chronic ulcers in levamisole-adulterated cocaine abusers: Clinicopathologic wariants from the same exposure. J Am Acad Dermatol. 68: AB227.
  • Michaud, K.; Grabherr, S.; Shiferaw, K.; Doenz, F.; Augsburger, M. & Mangin, P. 2014. Acute coronary syndrome after levamisole-adultered cocaine abuse. J Forensic Leg Med. 21: 48 –52.
  • Morley, S.R.; Hall, J.C.; Forrest, A.R.W. & Galloway J.H. 2006. Levamisole as a contaminant of illicit cocaine. J Clandestine Lab Invest Chemists Assoc. 16: 11.
  • National Database STUPS (INPS). 2012. Cocaine: Données essentielles. France: Observatoire Français des Drogues et des Toxicomanies.
  • Pecci, E.; Gregorini, G.; Sinigaglia, P.; Bozzola, G.; Tassi, G.; Ferremi, P. & Latronico, N. 2013. Diffuse alveolar haemorrhage (DAH) in levamisole-adultered cocaine abuser resolved by rFVIIa infusion. La Presse Médicale, 16th International Vasculitis et Amp, ANCA workshop, April 14–17 2013, Paris France.
  • Perkisas, S.; Vrelust, I.; Martin, M. & Gadisseur, A. 2011. A warning about agranulocytosis with the use of cocaine adulterated with levamisole. Acta Clin Belg. 66 (3 ): 226 –7.
  • Raymon, L.P. & Isenschmid, D.S. 2009. Letter to the editor: The possible role of levamisole in illicit cocaine preparations. J Anal Toxicol. 33: 620 –622.
  • Richard, N.; Arditti, J.; Pepin, G.; Mallaret, M. & Castot, A. 2010. Drames (deaths related to drug and illegal substance abuse): An identification tool of drug-related deaths in France. BEH 40–41: 416. Available at: http://www.invs.sante.fr/beh/2010/40_41/BEH_40_41.pdf
  • Schneider, S. & Meys, F. 2011. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005–2010. Forensic Sci Int. 212: 242 –6.
  • TEDI (Trans European Drug Information) trend report (TTR). 2013. Available at: http://www.tediproject.org/
  • World Drug Report. 2011. Available at: http://www.unodc.org/documents/data-and-analysis/WDR2011/World_Drug_Report_2011_ebook.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.